Rodman & Renshaw Maintains Stryker Market Perform

Rodman & Renshaw maintained its Stryker SYK Market Perform rating in a research report published today. In the report, Rodman & Renshaw states, "Stryker reported Q2 numbers yesterday with revenues coming in at $2.05 billion and adjusted EPS of $0.90. Core recon revenues did not inspire, and growth primarily was delivered by contribution from OUS, MedSurg, and acquisitions." Shares of Stryker closed today at $56.91, down 3.80% from Tuesday's market close.